Cutaneovisceral angiomatosis with thrombocytopenia

Vinay Prasad1, Steven J Fishman, John B Mulliken

  • 1Department of Pathology, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Insights

This study identifies a rare congenital vascular disorder in children, cutaneovisceral angiomatosis with thrombocytopenia, characterized by skin, GI, and sometimes lung lesions and low platelet counts.

Area of Science:

  • Vascular Biology
  • Pediatric Pathology
  • Dermatology

Background:

  • Multiple vascular lesions in children can present with significant morbidity.
  • Thrombocytopenia may be associated with complex vascular anomalies.

Purpose of the Study:

  • To describe a cohort of 10 children with a specific congenital vascular disorder.
  • To characterize the clinical, histopathologic, and treatment aspects of this condition.

Main Methods:

  • Clinical case series describing 10 pediatric patients.
  • Histopathologic examination of cutaneous, gastrointestinal, and pulmonary lesions.
  • Endoscopic evaluation of gastrointestinal tract.

Main Results:

  • Patients presented with congenital skin lesions, gastrointestinal bleeding (hematemesis/melena), and thrombocytopenia.
  • Vascular lesions involved skin, GI tract, and in some, lungs, bone, liver, spleen, or muscle.
  • Histopathology revealed thin-walled vascular channels with endothelial hyperplasia and PAS-positive deposits.

Conclusions:

  • The findings define a congenital proliferative disorder, termed cutaneovisceral angiomatosis with thrombocytopenia.
  • This disorder is characterized by distinctive histopathologic features and can require antiangiogenic therapy for severe bleeding.
  • Potential primary platelet defect may contribute to thrombocytopenia in some cases.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.